Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Zevra Therapeutics (ZVRA) Debt Ratio: 2014-2025

Historic Debt Ratio for Zevra Therapeutics (ZVRA) over the last 6 years, with Sep 2025 value amounting to 0.23.

  • Zevra Therapeutics' Debt Ratio fell 26.19% to 0.23 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.23, marking a year-over-year decrease of 26.19%. This contributed to the annual value of 0.33 for FY2024, which is 34.61% up from last year.
  • Zevra Therapeutics' Debt Ratio amounted to 0.23 in Q3 2025, which was down 4.16% from 0.24 recorded in Q2 2025.
  • Zevra Therapeutics' 5-year Debt Ratio high stood at 0.40 for Q2 2024, and its period low was 0.01 during Q1 2021.
  • Moreover, its 3-year median value for Debt Ratio was 0.25 (2024), whereas its average is 0.26.
  • In the last 5 years, Zevra Therapeutics' Debt Ratio surged by 235.35% in 2024 and then slumped by 41.37% in 2025.
  • Zevra Therapeutics' Debt Ratio (Quarterly) stood at 0.01 in 2021, then reached 0.11 in 2022, then skyrocketed by 123.62% to 0.25 in 2023, then spiked by 34.61% to 0.33 in 2024, then declined by 26.19% to 0.23 in 2025.
  • Its Debt Ratio stands at 0.23 for Q3 2025, versus 0.24 for Q2 2025 and 0.35 for Q1 2025.